Oisin Biotechnologies is a rejuvenation biotechnology company which received its seed funding from the Methuselah Foundation and SENS Research Foundation a few years ago. The current focus of Oisin is the targeted clearance of senescent cells, using drugs sometimes referred to as senolytics. Senescent cells are one of the hallmarks of aging, and as they…

We have been busy advocating for rejuvenation biotechnology. Elena Milova recently attended the first International Longevity and Cryopreservation Summit in Madrid, with a talk about how to deliver the most effective messages to engage the general public to support aging and rejuvenation research. We will shortly have a number of exciting articles about the conference,…

The breaking news today is that yet another research group has entered the field of senescent cell clearance to treat aging. Therapies that remove senescent cells are known as senolytics, and they have been a hot topic for the past year or so. Before we talk about the new study, let’s take a look at…

The SENS Research Foundation (SRF) is a 501(c)(3) non-profit organization whose focus is on developing and ensuring widespread access to rejuvenation biotechnologies meant to bring the pathologies of old age under comprehensive medical control. SRF was co-founded in March 2009 by Michael Kope, Dr. Aubrey de Grey, Jeff Hall, Sarah Marr, and Kevin Perrott. The approach to…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD